NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches

• Wenxue Ma,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Alejandro Gutierrez,

  Affiliation Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children’s Hospital Boston, Boston, Massachusetts, United States of America

  ⨯
• Daniel J. Goff,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Ifat Geron,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Anil Sadarangani,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Christina A. M. Jamieson,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Angela C. Court,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Alice Y. Shih,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Qingfei Jiang,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Christina C. Wu,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Kang Li,

  Affiliation Oncology Research Unit, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Kristen M. Smith,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Leslie A. Crews,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Neil W. Gibson,

  Affiliation Oncology Research Unit, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Ida Deichaite,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Sheldon R. Morris,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Ping Wei,

  Affiliation Oncology Research Unit, Pfizer Global Research and Development, La Jolla Laboratories, San Diego, California, United States of America

  ⨯
• Dennis A. Carson,

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• A. Thomas Look,

  Affiliation Department of Pediatric Oncology, Dana-Farber Cancer Institute and Children’s Hospital Boston, Boston, Massachusetts, United States of America

  ⨯
•  [ ... ],
• Catriona H. M. Jamieson

  * E-mail: cjamieson@ucsd.edu

  Affiliation Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America

  ⨯
• [ view all ]
• [ view less ]